Contact

All Stories

  1. Sodium load of novel antibiotics: considerations for nephrologists and clinicians

    Article • International Urology and Nephrology, December 2025, Springer Science + Business Media

    Dr Antonio Bellasi

  2. Experience in Peritoneal Dialysis

    Article • Kidney360, September 2025, Wolters Kluwer Health

    Dr Antonio Bellasi

  3. Usability of machine learning algorithms based on electronic health records for the prediction of acute kidney injury and transition to acute kidney disease: A proof of concept study

    Article • PLOS One, July 2025, PLOS

    Dr Antonio Bellasi

  4. Pathophysiology of chronic kidney disease–mineral bone disorder (CKD-MBD): from adaptive to maladaptive mineral homeostasis

    Article • Clinical Kidney Journal, March 2025, Oxford University Press (OUP)

    Dr Antonio Bellasi

  5. Update on current and emerging treatment paradigms for hyperphosphatemia in chronic kidney disease

    Article • Expert Opinion on Pharmacotherapy, December 2024, Taylor & Francis

    Dr Antonio Bellasi

  6. Bioimpedance Analysis in CKD and HF Patients: A Critical Review of Benefits, Limitations, and Future Directions

    Article • Journal of Clinical Medicine, October 2024, MDPI AG

    Dr Antonio Bellasi

  7. Phosphorous metabolism and manipulation in chronic kidney disease

    Article • Nephrology, October 2024, Wiley

    Dr Antonio Bellasi

  8. Cardiovascular calcification and renal function: A dysfunctional liaison

    Article • Atherosclerosis, August 2024, Elsevier

    Dr Antonio Bellasi

  9. Performance of [18F]FDG PET/CT in Diagnosing Cyst Infections in Patients with Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and a Bivariate Meta-Analysis

    Article • Diagnostics, July 2024, MDPI AG

    Dr Antonio Bellasi

  10. Papillary necrosis, fluid intake, and sickle cell nephropathy: lessons for the clinical nephrologist

    Article • Journal of Nephrology, July 2024, Springer Science + Business Media

    Dr Antonio Bellasi

  11. Ethnic and seasonal variations in FGF-23 and markers of chronic kidney disease–mineral and bone disorder

    Article • Clinical Kidney Journal, June 2024, Oxford University Press (OUP)

    Dr Antonio Bellasi

  12. QTc interval prolongation independently associates with FGF23 and predicts mortality in predialysis CKD.

    Article • Cardiorenal Medicine, January 2024, Karger Publishers

    Dr Antonio Bellasi

  13. New Challenges in Heart Failure with Reduced Ejection Fraction: Managing Worsening Events

    Article • Journal of Clinical Medicine, November 2023, MDPI AG

    Dr Antonio Bellasi

  14. Peritoneal dialysis discontinuation: to the root of the problem

    Article • Journal of Nephrology, September 2023, Springer Science + Business Media

    Dr Antonio Bellasi

  15. Finerenone: Questions and Answers—The Four Fundamental Arguments on the New-Born Promising Non-Steroidal Mineralocorticoid Receptor Antagonist

    Article • Journal of Clinical Medicine, June 2023, MDPI AG

    Dr Antonio Bellasi

  16. The Impact of Cholecaciferol Supplementation on Bone Mineral Density in Long-Term Kidney Transplant Recipients

    Article • Biomolecules, March 2023, MDPI AG

    Dr Antonio Bellasi

  17. Long-term kidney function recovery and mortality after COVID-19-associated acute kidney injury: an international multi-centre observational cohort study

    Article • EClinicalMedicine, January 2023, Elsevier

    Dr Antonio Bellasi, Dr Richard W Issitt

  18. Early Neurological ASsessment with pupillometrY during Cardiac Arrest REsuscitation (EASY-CARE): protocol for an observational multicentre prospective study

    Article • BMJ Open, December 2022, BMJ

    Dr Antonio Bellasi

  19. What electronic health records can and cannot tell us in the era of big data

    Article • Atherosclerosis, October 2022, Elsevier

    Dr Antonio Bellasi

  20. The “FIFTY SHADOWS” of the RALES Trial: Lessons about the Potential Risk of Dietary Potassium Supplementation in Patients with Chronic Kidney Disease

    Article • Journal of Clinical Medicine, July 2022, MDPI AG

    Dr Antonio Bellasi

  21. Machine learning for prediction of in-hospital mortality in coronavirus disease 2019 patients: results from an Italian multicenter study

    Article • Journal of Cardiovascular Medicine, July 2022, Wolters Kluwer Health

    Dr Antonio Bellasi

  22. Combined Role of Troponin and Natriuretic Peptides Measurements in Patients With Covid-19 (from the Cardio-COVID-Italy Multicenter Study)

    Article • The American Journal of Cardiology, March 2022, Elsevier

    Dr Antonio Bellasi

  23. Bone Mineral Density Changes in Long-Term Kidney Transplant Recipients: A Real-Life Cohort Study of Native Vitamin D Supplementation

    Article • Nutrients, January 2022, MDPI AG

    Dr Antonio Bellasi

  24. Retinal endothelial dysfunction: A glance on long-term risk of kidney failure

    Article • Atherosclerosis, January 2022, Elsevier

    Dr Antonio Bellasi

  25. Twelve-lead electrocardiogram artefacts in patients with arteriovenous fistulas for haemodialysis

    Article • European Heart Journal - Case Reports, November 2021, Oxford University Press (OUP)

    Dr Antonio Bellasi

  26. Bone metabolism and cardiovascular disease: An overlooked association?

    Article • Atherosclerosis, October 2021, Elsevier

    Dr Antonio Bellasi

  27. Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19

    Article • International Journal of Infectious Diseases, July 2021, Elsevier

    Dr Antonio Bellasi

  28. Vascular Calcification Progression Modulates the Risk Associated with Vascular Calcification Burden in Incident to Dialysis Patients

    Article • Cells, May 2021, MDPI AG

    Dr Antonio Bellasi

  29. Effects of Myo-inositol Hexaphosphate (SNF472) on Bone Mineral Density in Patients Receiving Hemodialysis

    Article • Clinical Journal of the American Society of Nephrology, April 2021, American Society of Nephrology

    Dr Antonio Bellasi

  30. Predictive Value of Measures of Vascular Calcification Burden and Progression for Risk of Death in Incident to Dialysis Patients

    Article • Journal of Clinical Medicine, January 2021, MDPI AG

    Dr Antonio Bellasi

  31. Thromboembolic and Bleeding Risk in Atrial Fibrillation Patients with Chronic Kidney Disease: Role of Anticoagulation Therapy

    Article • Journal of Clinical Medicine, December 2020, MDPI AG

    Dr Antonio Bellasi

  32. Sevelamer Use, Vitamin K Levels, Vascular Calcifications, and Vertebral Fractures in Hemodialysis Patients: Results from the VIKI Study

    Article • Journal of Bone and Mineral Research, December 2020, Wiley

    Dr Antonio Bellasi, Prof. Maurizio Gallieni

  33. Effects of SNF472, a Novel Inhibitor of Hydroxyapatite Crystallization in Patients Receiving Hemodialysis — Subgroup Analyses of the CALIPSO Trial

    Article • Kidney International Reports, December 2020, Elsevier

    Dr Antonio Bellasi

  34. Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID‐19. Results of the Cardio‐COVID‐Italy multicentre study

    Article • European Journal of Heart Failure, November 2020, Wiley

    Dr Antonio Bellasi

  35. Pulmonary embolism in patients with COVID-19: characteristics and outcomes in the Cardio-COVID Italy multicenter study

    Article • Clinical Research in Cardiology, November 2020, Springer Science + Business Media

    Dr Antonio Bellasi

  36. Association of Troponin Levels With Mortality in Italian Patients Hospitalized With Coronavirus Disease 2019

    Article • JAMA Cardiology, November 2020, American Medical Association (AMA)

    Dr Antonio Bellasi

  37. English–Latin nomenclature conundrum: should we use kidneylogy, kidneylogist?

    Article • Kidney International, November 2020, Elsevier

    Dr Antonio Bellasi

  38. International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium

    Article • npj Digital Medicine, August 2020, Springer Science + Business Media

    Dr Antonio Bellasi

  39. Is peritoneal dialysis superior to hemodialysis as far as cardiovascular risk? Another unsolved dilemma for maintenance dialysis

    Article • Atherosclerosis, August 2020, Elsevier

    Dr Antonio Bellasi

  40. Feasibility of routine ultrasound-guided percutaneous transluminal angioplasty in the treatment of native arteriovenous fistula dysfunction

    Article • The Journal of Vascular Access, July 2020, SAGE Publications

    Dr Antonio Bellasi, Prof. Maurizio Gallieni

  41. Glifozines and cardiorenal outcomes

    Article • Minerva Cardioangiologica, June 2020, Edizioni Minerva Medica

    Dr Antonio Bellasi

  42. Correction to: Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study

    Article • Journal of Nephrology, May 2020, Springer Science + Business Media

    Dr Antonio Bellasi

  43. Kidney Diseases: Challenges and Opportunities of the Third Millenium. How can digital health help the National Health System?

    Article • AboutOpen, March 2020, Aboutscience Srl

    Dr Antonio Bellasi

  44. Slowing Progression of Cardiovascular Calcification With SNF472 in Patients on Hemodialysis

    Article • Circulation, March 2020, Wolters Kluwer Health

    Dr Antonio Bellasi

  45. Therapeutic management of HIV-infected patients with chronic kidney disease

    Article • Journal of Nephrology, February 2020, Springer Science + Business Media

    Dr Antonio Bellasi

  46. Adverse Drug Reactions during Real-Life Use of Direct Oral Anticoagulants in Italy: An Update Based on Data from the Italian National Pharmacovigilance Network

    Article • Cardiorenal Medicine, January 2020, Karger Publishers

    Dr Antonio Bellasi

  47. New scenarios in secondary hyperparathyroidism: etelcalcetide. Position paper of working group on CKD-MBD of the Italian Society of Nephrology

    Article • Journal of Nephrology, December 2019, Springer Science + Business Media

    Dr Antonio Bellasi

  48. Associations between echocardiographic findings and prospective changes in residual renal function in patients new to peritoneal dialysis

    Article • Scientific Reports, December 2019, Springer Science + Business Media

    Dr Antonio Bellasi

  49. Mineral and Electrolyte Disorders With SGLT2i Therapy

    Article • JBMR Plus, November 2019, Oxford University Press (OUP)

    Dr Antonio Bellasi

  50. Trial design and baseline characteristics of CaLIPSO: a randomized, double-blind placebo-controlled trial of SNF472 in patients receiving haemodialysis with cardiovascular calcification

    Article • Clinical Kidney Journal, October 2019, Oxford University Press (OUP)

    Dr Antonio Bellasi

  51. Chronic Kidney Disease: The Silent Epidemy

    Article • Journal of Clinical Medicine, October 2019, MDPI AG

    Dr Antonio Bellasi

  52. Associations of Calcium from Food Sources versus Phosphate Binders with Serum Calcium and FGF23 in Hemodialysis Patients

    Article • Journal of Clinical Medicine, October 2019, MDPI AG

    Dr Antonio Bellasi

  53. Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study

    Article • Journal of Nephrology, October 2019, Springer Science + Business Media

    Dr Antonio Bellasi

  54. Implication of Acute Kidney Injury in Heart Failure

    Article • Heart Failure Clinics, October 2019, Elsevier

    Dr Antonio Bellasi

  55. Nutritional Therapy Modulates Intestinal Microbiota and Reduces Serum Levels of Total and Free Indoxyl Sulfate and P-Cresyl Sulfate in Chronic Kidney Disease (Medika Study)

    Article • Journal of Clinical Medicine, September 2019, MDPI AG

    Dr Antonio Bellasi

  56. Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial

    Article • American Journal of Kidney Diseases, September 2019, Elsevier

    Dr Antonio Bellasi

  57. Kidney Disease in HIV Infection

    Article • Journal of Clinical Medicine, August 2019, MDPI AG

    Dr Antonio Bellasi

  58. Fractional Excretion of Phosphate (FeP) Is Associated with End-Stage Renal Disease Patients with CKD 3b and 5

    Article • Journal of Clinical Medicine, July 2019, MDPI AG

    Dr Antonio Bellasi

  59. Very Low Protein Diet for Patients with Chronic Kidney Disease: Recent Insights

    Article • Journal of Clinical Medicine, May 2019, MDPI AG

    Dr Antonio Bellasi

  60. Cardiac valve calcification and use of anticoagulants: Preliminary observation of a potentially modifiable risk factor

    Article • International Journal of Cardiology, March 2019, Elsevier

    Dr Antonio Bellasi

  61. Osteocalcin (bone GLA protein) levels, vascular calcifications, vertebral fractures and mortality in hemodialysis patients with diabetes mellitus

    Article • Journal of Nephrology, February 2019, Springer Science + Business Media

    Prof. Maurizio Gallieni, Dr Antonio Bellasi

  62. Classification of Cardiorenal Syndrome

    Article • January 2019, Elsevier

    Dr Antonio Bellasi

  63. Haemorragic and thromboembolic risk in CKD patients with non valvular atrial fibrillation: Do we need a novel risk score calculator?

    Article • International Journal of Cardiology, January 2019, Elsevier

    Dr Antonio Bellasi

  64. Cardiorenal Syndrome in Acute Kidney Injury

    Article • Seminars in Nephrology, January 2019, Elsevier

    Dr Antonio Bellasi

  65. Coronary artery calcium in the general population, patients with chronic kidney disease and diabetes mellitus

    Article • January 2019, Elsevier

    Dr Antonio Bellasi

  66. Chronic kidney disease: A model of impaired vascular remodeling

    Article • Atherosclerosis, December 2018, Elsevier

    Dr Antonio Bellasi

  67. Search for a reliable biomarker of acute kidney injury: to the heart of the problem

    Article • Annals of Translational Medicine, November 2018, AME Publishing Company

    Dr Antonio Bellasi

  68. Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options

    Article • Cardiorenal Medicine, October 2018, Karger Publishers

    Dr Antonio Bellasi

  69. Cardiorenal Syndrome: An Overview

    Article • Advances in Chronic Kidney Disease, September 2018, Elsevier

    Dr Antonio Bellasi

  70. Safety and effectiveness of rivaroxaban and warfarin in moderate-to-advanced CKD: real world data

    Article • Journal of Nephrology, June 2018, Springer Science + Business Media

    Dr Antonio Bellasi

  71. Cardiovascular calcification: The emerging role of micronutrients

    Article • Atherosclerosis, June 2018, Elsevier

    Dr Antonio Bellasi

  72. Among markers of risk, uric acid remains a two-faced Janus awaiting definitive framing

    Article • Atherosclerosis, May 2018, Elsevier

    Dr Antonio Bellasi

  73. Vascular inflammation: A call for a specific and sensitive biomarker?

    Article • Atherosclerosis, April 2018, Elsevier

    Dr Antonio Bellasi

  74. CKD-MBD management: what is the role of parathyroidectomy? Results from a nationwide survey in Italy

    Article • Journal of Nephrology, March 2018, Springer Science + Business Media

    Dr Antonio Bellasi

  75. Intervista ad Antonio Bellasi

    Article • Giornale di Clinica Nefrologica e Dialisi, January 2018, Aboutscience Srl

    Dr Antonio Bellasi

  76. Nutritional therapy in autosomal dominant polycystic kidney disease

    Article • Journal of Nephrology, January 2018, Springer Science + Business Media

    Dr Antonio Bellasi

  77. The treatment of type 2 diabetes mellitus in patients with chronic kidney disease: What to expect from new oral hypoglycemic agents

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, November 2017, Elsevier

    Prof Domenico Russo, Dr Antonio Bellasi

  78. Vitamin D Metabolism and Potential Effects of Vitamin D Receptor Modulation in Chronic Kidney Disease

    Article • Current Drug Metabolism, September 2017, Bentham Science Publishers

    Dr Antonio Bellasi

  79. Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease

    Article • Expert Review of Clinical Pharmacology, September 2017, Taylor & Francis

    Dr Antonio Bellasi

  80. Nutritional therapy reduces protein carbamylation through urea lowering in chronic kidney disease

    Article • Nephrology Dialysis Transplantation, July 2017, Oxford University Press (OUP)

    Dr Antonio Bellasi

  81. Nonvitamin K-dependent oral anticoagulants (NOACs) in chronic kidney disease patients with atrial fibrillation

    Article • Thrombosis Research, July 2017, Elsevier

    Prof Domenico Russo, Dr Antonio Bellasi

  82. Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide

    Article • Therapeutics and Clinical Risk Management, June 2017, Dove Medical Press

    Dr Antonio Bellasi

  83. Pathophysiology of the cardio-renal syndromes types 1–5: An uptodate

    Article • Indian Heart Journal, March 2017, Elsevier

    Prof Domenico Russo, Dr Antonio Bellasi

  84. Epidemiology of low-proteinuric chronic kidney disease in renal clinics

    Article • PLOS One, February 2017, PLOS

    Dr Antonio Bellasi

  85. Assessment of intradialysis calcium mass balance by a single pool variable-volume calcium kinetic model

    Article • Hemodialysis International, February 2017, Wiley

    Camilla Bianchi, Dr Antonio Bellasi

  86. Cardiorenal acute kidney injury: Epidemiology, presentation, causes, pathophysiology and treatment

    Article • International Journal of Cardiology, January 2017, Elsevier

    Prof Domenico Russo, Dr Antonio Bellasi

  87. Type-5 cardiorenal syndrome (CRS-5): an up to date

    Article • Nephrology Point of Care, January 2017, SAGE Publications

    Dr Antonio Bellasi

  88. Correction of metabolic acidosis improves insulin resistance in chronic kidney disease

    Article • BMC Nephrology, October 2016, Springer Science + Business Media

    Dr Antonio Bellasi

  89. Prediction of hard cardiovascular events in HIV patients

    Article • Journal of Antimicrobial Chemotherapy, September 2016, Oxford University Press (OUP)

    Andrea Malagoli, Dr Antonio Bellasi

  90. Sudden cardiac death and chronic kidney disease: From pathophysiology to treatment strategies

    Article • International Journal of Cardiology, August 2016, Elsevier

    Prof Domenico Russo, Dr Antonio Bellasi

  91. The density of calcified plaques and the volume of calcium predict mortality in hemodialysis patients

    Article • Atherosclerosis, July 2016, Elsevier

    Dr Antonio Bellasi

  92. Shed a light on intradialytic calcium mass balance

    Article • Kidney International, June 2016, Elsevier

    Dr Antonio Bellasi

  93. Epicardial adipose tissue volume increase in hemodialysis patients treated with sevelamer or calcium-based phosphate binders: a substudy of the Renagel in new dialysis trial

    Article • Journal of Nephrology, April 2016, Springer Science + Business Media

    Dr Antonio Bellasi

  94. Serum calcium may not accurately predict intradialytic calcium mass transfer

    Article • Hemodialysis International, February 2016, Wiley

    Dr Antonio Bellasi

  95. Opponent's comments

    Article • Nephrology Dialysis Transplantation, January 2016, Oxford University Press (OUP)

    Dr Antonio Bellasi

  96. Coronary artery disease (CAD) in chronic kidney disease patients

    Article • Giornale di Techniche Nefrologiche e Dialitiche, January 2016, SAGE Publications

    Dr Antonio Bellasi

  97. Retarding CKD Progression: Readily Available through Comprehensive Nutritional Management?

    Article • Nephrology Point of Care, January 2016, SAGE Publications

    Dr Antonio Bellasi

  98. Single-Center Open-Label Randomized Study of Anemia Management Improvement in ESRD Patients with Secondary Hyperparathyroidism

    Article • Nephrology Point of Care, January 2016, SAGE Publications

    Dr Antonio Bellasi

  99. Pro: Should phosphate binders be used in chronic kidney disease stage 3–4?Opponent's comments

    Article • Nephrology Dialysis Transplantation, December 2015, Oxford University Press (OUP)

    Dr Antonio Bellasi

  100. Con: Phosphate binders in chronic kidney diseaseOpponent's comments

    Article • Nephrology Dialysis Transplantation, December 2015, Oxford University Press (OUP)

    Dr Antonio Bellasi

  101. Epicardial adipose tissue and coronary artery calcium predict incident myocardial infarction and death in HIV-infected patients

    Article • Journal of Cardiovascular Computed Tomography, November 2015, Elsevier

    Andrea Malagoli, Dr Antonio Bellasi

  102. EPICARDIAL ADIPOSE TISSUE AND CORONARY ARTERY CALCIUM INDEPENDENTLY PREDICT INCIDENT MYOCARDIAL INFARCTION AND DEATH IN HIV-INFECTED PATIENTS

    Article • Canadian Journal of Cardiology, October 2015, Elsevier

    Dr Antonio Bellasi

  103. Fibroblast growth factor 23 and parathyroid hormone predict extent of aortic valve calcifications in patients with mild to moderate chronic kidney disease

    Article • Clinical Kidney Journal, September 2015, Oxford University Press (OUP)

    Dr Antonio Bellasi, Prof Domenico Russo

  104. SP575PREDICTIVE VALUE OF MEASURES OF VASCULAR CALCIFICATION FOR RISK OF DEATH IN INCIDENT DIALYSIS PATIENTS

    Article • Nephrology Dialysis Transplantation, May 2015, Oxford University Press (OUP)

    Dr Antonio Bellasi

  105. Emerging drugs for secondary hyperparathyroidism

    Article • Expert Opinion on Emerging Drugs, February 2015, Informa Healthcare

    Dr Antonio Bellasi

  106. Opponent's comments

    Article • Nephrology Dialysis Transplantation, February 2015, Oxford University Press (OUP)

    Dr Antonio Bellasi

  107. The Importance of Ventricular-Vascular Uncoupling

    Article • JACC Heart Failure, January 2015, Elsevier

    Dr Antonio Bellasi

  108. Cardiovascular Biomarkers in Chronic Kidney Disease: State of Current Research and Clinical Applicability

    Article • Disease Markers, January 2015, Hindawi Publishing Corporation

    Dr Antonio Bellasi

  109. Ivabradine, Heart Failure and Chronic Kidney Disease

    Article • Nephrology Point of Care, January 2015, SAGE Publications

    Dr Antonio Bellasi

  110. Nephrology@Point of Care: A New Journal for Hands-On Clinicians

    Article • Nephrology Point of Care, January 2015, SAGE Publications

    Dr Antonio Bellasi

  111. Vascular calcification, bone and mineral metabolism after kidney transplantation

    Article • World Journal of Transplantation, January 2015, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Antonio Bellasi

  112. Intact parathyroid hormone levels are associated with increased carotid intima media thickness in HIV infected patients

    Article • Atherosclerosis, December 2014, Elsevier

    Professor Vincenzo - Rochira, Dr Antonio Bellasi

  113. Not all diabetic patients were created equal: How to discriminate risk?

    Article • Atherosclerosis, November 2014, Elsevier

    Dr Antonio Bellasi

  114. Erratum to: Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study

    Article • Journal of Nephrology, August 2014, Springer Science + Business Media

    Prof Domenico Russo, Dr Antonio Bellasi

  115. Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study

    Article • Journal of Nephrology, July 2014, Springer Science + Business Media

    Prof Domenico Russo, Dr Antonio Bellasi

  116. Phosphate Metabolism Modulation in Chronic Kidney Disease: When, How and to What Extent?

    Article • Nephro-Urology Monthly, April 2014, Kowsar Medical Institute

    Dr Antonio Bellasi

  117. Effects of phosphorus-restricted diet and phosphate-binding therapy on outcomes in patients with chronic kidney disease

    Article • Journal of Nephrology, March 2014, Springer Science + Business Media

    Dr Antonio Bellasi, Prof Domenico Russo

  118. Sevelamer Is Cost-Saving vs. Calcium Carbonate in Non-Dialysis-Dependent CKD Patients in Italy: A Patient-Level Cost-Effectiveness Analysis of the INDEPENDENT Study

    Article • Blood Purification, January 2014, Karger Publishers

    Prof Domenico Russo, Dr Antonio Bellasi

  119. Physical Activity in Chronic Kidney Disease: a Plausible Approach to Vascular Calcification?

    Article • Kidney and Blood Pressure Research, January 2014, Karger Publishers

    Dr Antonio Bellasi

  120. Hybrid myocardial imaging for risk stratification prior to kidney transplantation: Added value of coronary calcium and epicardial adipose tissue

    Article • Journal of Nuclear Cardiology, December 2013, Elsevier

    Dr Antonio Bellasi

  121. Sevelamer Versus Calcium Carbonate in Incident Hemodialysis Patients: Results of an Open-Label 24-Month Randomized Clinical Trial

    Article • American Journal of Kidney Diseases, October 2013, Elsevier

    Prof Domenico Russo, Dr Antonio Bellasi

  122. Hybrid Myocardial Imaging for Cardiovascular Risk Stratification Prior to Kidney Transplantation: Added Value of Coronary Calcium and Epicardial Adipose Tissue

    Article • Canadian Journal of Cardiology, October 2013, Elsevier

    Dr Antonio Bellasi

  123. Inverse Correlation Between Vascular Calcification and Bone Mineral Density in Human Immunodeficiency Virus-Infected Patients

    Article • Calcified Tissue International, August 2013, Springer Science + Business Media

    Professor Vincenzo - Rochira, Dr Antonio Bellasi

  124. Urolithiasis associated with atazanavir may mask a metabolic 'channelling' bias

    Article • Journal of Antimicrobial Chemotherapy, August 2013, Oxford University Press (OUP)

    Dr Antonio Bellasi

  125. Epicardial adipose tissue predicts mortality in incident hemodialysis patients: a substudy of the Renagel in New Dialysis trial

    Article • Nephrology Dialysis Transplantation, July 2013, Oxford University Press (OUP)

    Dr Antonio Bellasi

  126. Cinacalcet: the chemical parathyroidectomy?

    Article • Clinical Kidney Journal, May 2013, Oxford University Press (OUP)

    Dr Antonio Bellasi

  127. QT interval in CKD and haemodialysis patients

    Article • Clinical Kidney Journal, January 2013, Oxford University Press (OUP)

    Dr Antonio Bellasi

  128. Paricalcitol and Cardiorenal Outcome: From the IMPACT Study to Clinical Practice

    Article • Blood Purification, January 2013, Karger Publishers

    Dr Antonio Bellasi

  129. Does It Make Sense to Measure Only the Brachial Blood Pressure?

    Article • Blood Purification, January 2013, Karger Publishers

    Dr Antonio Bellasi

  130. Which Vitamin D in CKD-MBD? The Time of Burning Questions

    Article • BioMed Research International, January 2013, Hindawi Publishing Corporation

    Dr Antonio Bellasi

  131. Phosphate balance and organ damage

    Article • Giornale di Techniche Nefrologiche e Dialitiche, January 2013, Wichtig

    Dr Antonio Bellasi

  132. Phosphate binders in moderate chronic kidney disease: where do we stand?

    Article • Journal of Nephrology, January 2013, Wichtig

    Prof Domenico Russo, Dr Antonio Bellasi

  133. Vitamin D Status and Coronary Flow Reserve Measured by Positron Emission Tomography: A Co-Twin Control Study

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2013, Endocrine Society

    Dr Antonio Bellasi

  134. Cardiac valve calcification: an immutable pathologic finding in chronic kidney disease?

    Article • Journal of Nephrology, January 2013, SAGE Publications

    Dr Antonio Bellasi

  135. Report from 1st National Meeting of Cardionephrology Study Group of Italian Society of Nephrology

    Article • Giornale di Techniche Nefrologiche e Dialitiche, January 2013, Aboutscience Srl

    Dr Antonio Bellasi

  136. Subendocardial Viability Ratio Predicts Cardiovascular Mortality in Chronic Kidney Disease Patients

    Article • Blood Purification, January 2013, Karger Publishers

    Dr Antonio Bellasi

  137. Arterial Stiffness, Pulse Wave Analyses: What Can’t Blood Pressure Tell you in Chronic Kidney Disease

    Article • Current Hypertension Reviews, December 2012, Bentham Science Publishers

    Dr Antonio Bellasi, Prof Domenico Russo

  138. Phosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients

    Article • Nephrology Dialysis Transplantation, November 2012, Oxford University Press (OUP)

    Prof. Carmine Zoccali, Dr Antonio Bellasi

  139. Arterial Stiffness, Pulse Wave Analyses: What Can't Blood Pressure Tell you in Chronic Kidney Disease

    Article • Current Hypertension Reviews, November 2012, Bentham Science Publishers

    Prof Domenico Russo, Dr Antonio Bellasi

  140. Blood pressure variability and outcomes in chronic kidney disease

    Article • Nephrology Dialysis Transplantation, September 2012, Oxford University Press (OUP)

    Dr Antonio Bellasi

  141. Vascular imaging in chronic kidney disease

    Article • Current Opinion in Nephrology & Hypertension, July 2012, Wolters Kluwer Health

    Dr Antonio Bellasi

  142. Integration of clinical and imaging data to predict death in hemodialysis patients

    Article • Hemodialysis International, May 2012, Wiley

    Dr Antonio Bellasi

  143. Bone and mineral diseases - 2

    Article • Nephrology Dialysis Transplantation, May 2012, Oxford University Press (OUP)

    Dr Antonio Bellasi

  144. Mortality in Kidney Disease Patients Treated with Phosphate Binders: A Randomized Study

    Article • Clinical Journal of the American Society of Nephrology, January 2012, American Society of Nephrology

    Dr Antonio Bellasi, Prof Domenico Russo, Dr. Biagio Raffaele Di Iorio

  145. Impact of Vascular Calcification on QT Interval and QT Dispersion in CKD and Dialysis Patients

    Article • American Journal of Nephrology, January 2012, Karger Publishers

    Dr Antonio Bellasi

  146. Is time on cardiopulmonary bypass during cardiac surgery associated with acute kidney injury requiring dialysis?

    Article • Hemodialysis International, November 2011, Wiley

    Dr Antonio Bellasi

  147. All-cause Mortality in Hemodialysis Patients with Heart Valve Calcification

    Article • Clinical Journal of the American Society of Nephrology, August 2011, Wolters Kluwer Health

    Dr Antonio Bellasi

  148. Cardiac valve calcification is a marker of vascular disease in prevalent hemodialysis patients

    Article • Journal of Nephrology, June 2011, SAGE Publications

    Dr Antonio Bellasi

  149. Variability of pulse wave velocity and mortality in chronic hemodialysis patients

    Article • Hemodialysis International, April 2011, Wiley

    Prof Domenico Russo, Dr Antonio Bellasi

  150. Intervista ad Antonio Bellasi

    Article • Giornale di Techniche Nefrologiche e Dialitiche, April 2011, SAGE Publications

    Dr Antonio Bellasi

  151. Chronic Kidney Disease Progression and Outcome According to Serum Phosphorus in Mild-to-Moderate Kidney Dysfunction

    Article • Clinical Journal of the American Society of Nephrology, April 2011, Wolters Kluwer Health

    Dr Antonio Bellasi

  152. Coronary Artery Calcification Progression Is Associated with Arterial Stiffness and Cardiac Repolarization Deterioration in Hemodialysis Patients

    Article • Kidney and Blood Pressure Research, January 2011, Karger Publishers

    Prof Domenico Russo, Dr Antonio Bellasi

  153. Arterial Stiffness in Chronic Kidney Disease: The Usefulness of a Marker of Vascular Damage

    Article • International Journal of Nephrology, January 2011, Wiley

    Dr Antonio Bellasi

  154. Vascular calcification in chronic kidney disease: usefulness of a marker of vascular damage

    Article • Journal of Nephrology, January 2011, SAGE Publications

    Dr Antonio Bellasi

  155. Arterial Accelerated Aging in Dialysis Patients: The Clinical Impact of Vascular Calcification

    Article • Current Vascular Pharmacology, July 2009, Bentham Science Publishers

    Prof. Maurizio Gallieni, Dr Antonio Bellasi

  156. Combined Impact of Age and Estimated Glomerular Filtration Rate on In-Hospital Mortality After Percutaneous Coronary Intervention for Acute Myocardial Infarction (from the American College of Cardiology National Cardiovascular Data Registry)

    Article • The American Journal of Cardiology, March 2009, Elsevier

    Dr Antonio Bellasi

  157. Investigation of Gender Heterogeneity in the Associations of Serum Phosphorus With Incident Coronary Artery Disease and All-Cause Mortality

    Article • American Journal of Epidemiology, October 2008, Oxford University Press (OUP)

    Dr Antonio Bellasi

  158. Phosphorus levels are associated with subclinical atherosclerosis in the general population

    Article • Atherosclerosis, August 2008, Elsevier

    Dr Antonio Bellasi

  159. Impact of race and chronic kidney disease on 1-year outcome in patients undergoing percutaneous coronary interventions: A single tertiary center experience

    Article • American Heart Journal, June 2008, Elsevier

    Dr Antonio Bellasi

  160. Markers of vascular disease do not differ in black and white hemodialysis patients despite a different risk profile

    Article • Atherosclerosis, March 2008, Elsevier

    Dr Antonio Bellasi

  161. Phosphate Binders

    Article • January 2008, Elsevier

    Dr Antonio Bellasi

  162. Cardiovascular Calcium: Assessment and Impact of Interventions

    Article • January 2008, Springer Science + Business Media

    Dr Antonio Bellasi

  163. New insights into ischemic heart disease in women.

    Article • Cleveland Clinic Journal of Medicine, August 2007, Cleveland Clinic Journal of Medicine

    Dr Antonio Bellasi

  164. Comparison of Prognostic Usefulness of Coronary Artery Calcium in Men Versus Women (Results from a Meta- and Pooled Analysis Estimating All-Cause Mortality and Coronary Heart Disease Death or Myocardial Infarction)

    Article • The American Journal of Cardiology, August 2007, Elsevier

    Dr Antonio Bellasi

  165. Review: Imaging to assess effect of medical therapy in patients with diabetes mellitus

    Article • The British Journal of Diabetes, July 2007, SAGE Publications

    Dr Antonio Bellasi

  166. Pulse Wave Velocity Is Inversely Related to Vertebral Bone Density in Hemodialysis Patients

    Article • Hypertension, June 2007, Wolters Kluwer Health

    Dr Antonio Bellasi

  167. Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients

    Article • Kidney International, April 2007, Elsevier

    Dr Antonio Bellasi

  168. VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: Techniques and Technologies to Assess Vascular Calcification

    Article • Seminars in Dialysis, March 2007, Wiley

    Dr Antonio Bellasi

  169. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients

    Article • Kidney International, March 2007, Elsevier

    Dr Antonio Bellasi

  170. Clinical Assessment of Vascular Calcification

    Article • Advances in Chronic Kidney Disease, January 2007, Elsevier

    Dr Antonio Bellasi

  171. Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysis

    Article • Nature Clinical Practice Neurology, January 2007, Springer Science + Business Media

    Dr Antonio Bellasi

  172. Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients

    Article • Kidney International, November 2006, Elsevier

    Dr Antonio Bellasi

  173. Accelerated vascular calcification and relative hypoparathyroidism in incident haemodialysis diabetic patients receiving calcium binders

    Article • Nephrology Dialysis Transplantation, September 2006, Oxford University Press (OUP)

    Dr Antonio Bellasi

  174. Development of a cardiovascular calcification index using simple imaging tools in haemodialysis patients

    Article • Nephrology Dialysis Transplantation, September 2006, Oxford University Press (OUP)

    Dr Antonio Bellasi

  175. Lipid-lowering therapy with statins in postmenopausal women: a few answered and many unanswered questions

    Article • Future Lipidology, August 2006, Taylor & Francis

    Dr Antonio Bellasi

  176. Phosphate binders: New products and challenges

    Article • Hemodialysis International, July 2006, Wiley

    Dr Antonio Bellasi

  177. Ischemia Imaging and Plaque Imaging in Diabetes: Complementary Tools to Improve Cardiovascular Risk Management

    Article • Diabetes Care, May 2006, American Diabetes Association

    Dr Antonio Bellasi

  178. Phosphate binders

    Article • American Journal of Health-System Pharmacy, April 2006, Oxford University Press (OUP)

    Dr Antonio Bellasi

  179. Ischemia Imaging and Plaque Imaging in Diabetes

    Article • Diabetes Care, November 2005, American Diabetes Association

    Dr Antonio Bellasi

  180. Diagnostic and prognostic value of coronary artery calcium screening

    Article • Current Opinion in Cardiology, September 2005, Wolters Kluwer Health

    Dr Antonio Bellasi

  181. Ethiopathogenesis, Diagnosis and Prevention of Vascular Calcification in End Stage Renal Disease

    Article • Current Medicinal Chemistry - Cardiovascular & Hematological Agents, April 2005, Bentham Science Publishers

    Dr Antonio Bellasi

  182. Coronary Artery Calcium Screening: Implications for Clinical Practice

    Article • Future Cardiology, March 2005, Taylor & Francis

    Dr Antonio Bellasi

  183. Salvage Insertion of Tunneled Central Venous Catheters in the Internal Jugular Vein after Accidental Catheter Removal

    Article • The Journal of Vascular Access, April 2004, SAGE Publications

    Dr Antonio Bellasi